食品伙伴網(wǎng)訊 據(jù)美國食品藥品管理局消息，8月11日美國FDA發(fā)布消息，更新膳食補充劑上市前安全通告指導意見草案。相關(guān)通告有助FDA在產(chǎn)品被售出之前識別安全隱患。
按照膳食補充劑健康教育法案的要求，生產(chǎn)商或者經(jīng)銷商需要在含新原料膳食補充劑上市前的75天前向FDA匯報，該新原料已被用于食品無風險的情況除外。如果含有非食品原料并且未在銷售的75天前向FDA匯報，那么會被判為摻假。
部分原文報道如下：
The U.S. Food and Drug Administration today issued a revised draft guidance to improve dietary supplement companies' new dietary ingredient （NDI） premarket safety notifications to the agency. These notifications help the agency identify safety concerns before products reach consumers.
Under the Dietary Supplement Health and Education Act （DSHEA）， the manufacturer or distributor must notify the FDA at least 75 days before beginning to market a dietary supplement that contains a new dietary ingredient （one that was not marketed in the United States before Oct. 15, 1994）， unless the NDI is used in the food supply without chemical alteration. Dietary supplements are considered adulterated if they contain an NDI not used in the food supply and the required notification has not been submitted to the FDA 75 days before marketing.
原文鏈接：
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm516197.htm
地區(qū)：
魯公網(wǎng)安備 37060202000128號
